Buying guide
Maestro
By Moon Surgical · surgical
- Price
- $300,000-$800,000· analyst estimate
- Availability
- Internal use only (not for retail).
- Maturity
- pilot
- Real-world use
- Yes, 1 verified deployment
Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.
Readiness
Maestro is internal use only (not for retail) at $300,000-$800,000 (analyst estimate), the 1 capability claim on file is all teleoperated-assisted with verified, 1 verified deployment is on file, and no incidents are on record.
- Availability
- internal-only
Internal use only (not for retail).
- Price honesty
- analyst-estimate
One price on file: $300,000-$800,000 (analyst estimate).
- Capability honesty
- teleoperated-assisted
1 reviewed claim: teleoperated-assisted, verified.
- Real-world use
- pilot
Maturity: pilot. 1 verified deployment in the registry.
- Safety record
- no-incidents
No incidents on record. 1 verified deployment on file.
What it claims to do
- Assists surgeryteleoperated-assisted· verifiedevidence ↗
Price
- $300,000-$800,000analyst estimate · How Much is a Surgical Robot? (2025 Edition) – R2 Surgical ↗ · as of 2025-01-01
Real-world use
- Jacksonville2023-09-26
Safety record
No incidents on record. 1 verified deployment on file.
Privacy
No privacy practices disclosed or on file for Maestro.
Specs
- notes
- Verified: Moon Surgical (private; Paris + San Carlos CA; CEO Anne Osdoit; board chair Fred Moll, Intuitive co-founder; backers Sofinnova + NVentures/NVIDIA) makes Maestro, a laparoscopic surgical-ASSISTANT/collaboration robot (holds/positions instruments alongside the surgeon, not a full teleop console). Commercial Maestro FDA 510(k)-cleared Jun 5 2024 (K240598); >1,100 patients treated across US + Europe (company-stated). ~$90M+ raised.
- AI-substance: genuine SHIPPED AI (notable): ScoPilot is a genuine SHIPPED, FDA-cleared AI feature (intraoperative scope control via NVIDIA Holoscan), with a PCCP - not merely demonstrated. This distinguishes Maestro from the teleop-only platforms in this cohort. Maestro itself is a collaborative/assist robot (an honest distinction from full master-slave teleop).
- CORRECTION (pathway): Maestro went the 510(k) route (K240598), NOT de novo (the dispatch hypothesized de novo). De novo around that time was Virtual Incision/MIRA and MMI/Symani - different companies.
- Claimed but NOT verified: CE mark status/date (unverified this pass); exact installed-system count; the 'industry's first AI on a commercial surgical robot' superlative (marketing); the >1,100-patients figure (company-sourced).
- console
- not a full master-slave teleoperation console
- products
- Maestro: a laparoscopic surgical-assistant platform (holds/positions instruments + endoscope alongside the surgeon). ScoPilot: shipped AI software (NVIDIA Holoscan-powered) for intraoperative scope control. Commercial Maestro FDA 510(k) K240598 cleared Jun 5 2024; ScoPilot FDA-cleared 2025 with a Predetermined Change Control Plan (PCCP).
- formFactor
- surgical (laparoscopic surgical-assistant / collaboration robot: holds + positions instruments alongside the surgeon; not full master-slave teleop)
- fda_clearance
- FDA 510(k) clearance under K240598 on June 5, 2024
- clearance_body
- FDA
- procedure_types
- laparoscopic
What's under the hood
No brain on file for Maestro.
Frequently asked questions
- Is the Maestro actually available for purchase?
- Not available to consumers. In internal use by Moon Surgical.Source: Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)
- What does the Maestro cost?
- Maestro costs $300,000-$800,000 one-time (analyst estimate).Source: How Much is a Surgical Robot? (2025 Edition) – R2 Surgical
- Does the Maestro really assists surgery?
- Verified at teleoperator-assisted autonomy; not fully autonomous.Source: Moon Surgical receives second FDA clearance, covering its commercial Maestro Robotic Surgery System -- PR Newswire, June 2024; FDA 510(k) cleared for commercial version; CE marked September 2023; 200+ patients treated at European pilot sites
- Where is the Maestro being used?
- Maestro is in use at: Jacksonville (2023-09-26).Source: Moon Surgical Announces First Clinical Cases in the U.S. Using Maestro System
- Is the Maestro safe?
- No incidents on record across 1 verified deployment.
- How does the Maestro handle privacy?
- No privacy practices disclosed or on file for Maestro.
- Who makes the Maestro?
- Maestro is made by Moon Surgical, based in San Carlos, California, USA.Source: Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024)
Video
Moon Surgical's overview of its Maestro surgical-assistance system. Maestro is operated by the surgical team; its ScoPilot feature automates scope and camera movement, not the surgery.
Manufacturer
Moon Surgical (registry record: /companies/moon-surgical)
Compare side by side
- Maestro vs Hugo RASby Medtronic · surgical
Sources
- Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024) · https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro
- FDA 510(k) K240598: Maestro System (cleared Jun 5 2024) · https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K240598
- Moon Surgical ScoPilot AI FDA clearance (with PCCP; NVIDIA Holoscan) · https://www.biospace.com/moon-surgical-scopilot-fda-nvidia-holoscan
- Moon Surgical raises $55.4M; Fred Moll board chair; NVentures-backed · https://www.massdevice.com/moon-surgical-funding-fred-moll/
- Moon Surgical receives second FDA clearance, covering its commercial Maestro Robotic Surgery System -- PR Newswire, June 2024; FDA 510(k) cleared for commercial version; CE marked September 2023; 200+ patients treated at European pilot sites · https://www.prnewswire.com/news-releases/moon-surgical-receives-second-fda-clearance-covering-its-commercial-maestro-robotic-surgery-system-302164186.html · 2024-06-05
- Moon Surgical official YouTube (@moonsurgical), embedded under standard YouTube embed terms. oEmbed author_url verified 2026-06-04. Maker product video; surgeon-teleoperated/assisted system, not autonomous. · https://www.youtube.com/watch?v=AuplMN-VpCU · 2026-06-04
- How Much is a Surgical Robot? (2025 Edition) – R2 Surgical · https://r2surgical.com/blogs/news/how-much-is-a-surgical-robot-2025-edition
- Moon Surgical Announces First Clinical Cases in the U.S. Using Maestro System · https://www.businesswire.com/news/home/20230926938682/en/Moon-Surgical-Announces-First-Clinical-Cases-in-the-U.S.-Using-Maestro-System · 2023-09-26
- First U.S. clinical cases performed with Moon Surgical's Maestro surgical robot · https://www.massdevice.com/first-cases-moon-surgical-maestro-surgical-robot/ · 2023-09-26
Recent coverage
- Moon Surgical wins first FDA 510(k) clearance for surgical robotAgentRecon · 2026-06-25
- Moon Surgical wins FDA clearance for MaestroAgentRecon · 2025-06-01
Machine-readable: this page as markdown.
Canonical: https://deploy.report/models/moon-maestro